瑞穗银行:维持Verastem评级

证券之星
19 Dec 2024

瑞穗银行:维持verastem(VSTM.US)评级,由优于大市调整至优于大市评级,目标价由7.00美元调整至9.00美元。Verastem(VSTM.US)公司简介:Verastem Inc是一家后期开发生物制药公司,致力于为抗癌患者开发新药。其产品线专注于新型抗癌药物,这些药物可抑制癌症中促进癌细胞存活和肿瘤生长的关键信号通路,特别是RAF/MEK抑制和FAK抑制。以上内容为证券之星据公开信息...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10